JPMorgan Chase & Co. Reduces Position in Option Care Health, Inc. (NASDAQ:OPCH)

JPMorgan Chase & Co. trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 3.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,166,528 shares of the company's stock after selling 46,460 shares during the period. JPMorgan Chase & Co. owned about 0.69% of Option Care Health worth $36,512,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Wellington Management Group LLP lifted its stake in shares of Option Care Health by 15.5% during the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock valued at $310,650,000 after buying an additional 1,328,326 shares during the period. FMR LLC lifted its stake in shares of Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after purchasing an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP lifted its stake in shares of Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock worth $203,204,000 after purchasing an additional 599,589 shares during the period. State Street Corp boosted its holdings in shares of Option Care Health by 1.4% during the third quarter. State Street Corp now owns 6,257,172 shares of the company's stock worth $195,849,000 after purchasing an additional 83,395 shares during the last quarter. Finally, Thrivent Financial for Lutherans grew its position in shares of Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company's stock valued at $183,541,000 after purchasing an additional 404,811 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price target on the stock. Truist Financial decreased their target price on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. Barrington Research dropped their price target on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Finally, Bank of America downgraded Option Care Health from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $30.14.

Option Care Health Trading Up 0.3 %

Shares of Option Care Health stock traded up $0.06 during trading hours on Tuesday, hitting $23.94. The company's stock had a trading volume of 1,389,674 shares, compared to its average volume of 1,266,416. The business has a fifty day moving average of $23.20 and a 200 day moving average of $27.81. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $4.07 billion, a PE ratio of 20.12, a P/E/G ratio of 2.43 and a beta of 1.31.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the stock in a transaction on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company's stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.